// App-Quantinova.ai

: Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort

Researchers

Presenter

  • Javier de la Rubia

Principal Investigators

  • Maria Esther Clavero Sanchez

  • Elham Askari

  • Alfonso Garcia de Coca

  • Ana Maldonado

  • Margarita Fernandez De La Mata

  • Fernando Escalante

  • Ana Garcia-Feria

  • Rafael Rios

  • Venancio Conesa

  • Maria Aranzazu Bermudez

  • Beatriz Merchan

  • Alberto Velasco

  • Maria Jesus Blanchard

  • Antonia Sampol

  • Eukene Gainza González

  • Pedro M Hernandez

  • Veronica Gonzalez-Calle

  • Adrian Alegre

Medical Centers

  • Hematology, Hospital Dr. Peset, Valencia, Spain

  • Department of Hematology, Hospital Universitari Son Espases, IdISBa, Palma de Mallorca, Spain

  • Departamento De Hematología, Hospital Universitario De Salamanca (HUSAL), Salamanca, ESP

  • Hematology, Hospital Virgen de las Nieves, Granada, ESP

  • Hospital Universitario Son Espases, Palma De Mallorca, ESP

  • Hospital Morales Meseguer, IMIB-Arrixaca, Universidad de Murcia, Murcia, Spain

  • Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain

  • Hospital Universitario Puerta de Hierro, Madrid, Spain

  • Hematology, Hospital Rey Juan Carlos, Móstoles, Spain

  • Hematology Service, Hospital Universitario Ramón y Cajal, Madrid, Spain

  • Univeritary Hospital La Princesa, Madrid, Spain

  • Hematology Department, Hospital Universitario de León, León, Spain

  • Hematology Department, Hospital Universitari i Politècnic La Fe, Catholic University of Valencia, Valencia, Spain

  • Hospital Universitario de Leon, Leon, Spain

  • Hematology, Hospital Doce de Octubre, Madrid, Spain

  • Servicio de Hematología, Hospital Clínico, Valladolid, Spain

  • Hematology, Hospital U San Pedro, Logroño, Spain

  • Hospital Universitario de Galdakao - Usansolo / Servicio de Hematología y Hemoterapia, Osakidetza - Servicio Vasco de Salud, Galdakao, Spain

  • Hospital Reina Sofia, Cordoba, Spain

  • HGU de Elche, Alicante, Spain

  • Hospital U. de Guadalajara, Guadalajara, Spain

  • Hospital Universitario Marqués de Valdecilla, Santander, ESP

  • Department of Hematology, Fundacion Jimenez Diaz University Hospital, Madrid, Spain

  • Hospital Universitario La Princesa, Madrid, Spain

Locations

  • Spain

  • Mexico

  • Venezuela

  • Nicaragua

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Multiple Myeloma

  • Thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • GSK2857916

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved